
VC firms back $30m series-B for Ava
A consortium of new and existing investors has backed a $30m series-B funding round for fertility tracking device maker Ava.
The majority of the funding came from existing investors, including Swisscom Ventures, Blue Ocean Ventures, Polytech Ecosystem Ventures and Zurcher Kantonbank (ZKB).
New investors included Swiss VC firm BtoV Partners and SVC, an investment vehicle managed by Credit Suisse.
The fresh capital will be used for further product research and development.
Previous funding
Swisscom and ZKB invested in a $2.6m seed round for Ava in November 2015, and both investors returned to take part in a $9.7m round alongside Blue Ocean Ventures and Polytech Ecosystem Ventures a year later.
Company
Founded in 2014 and headquartered in Zurich and San Francisco, Ava is a medical technology company developing a bracelet that detects a woman's fertility window.
The company is also working on clinical studies with the University Hospital of Zurich to expand its algorithms for use in pregnancy recognition, pregnancy monitoring, and possible use as a non-hormonal contraceptive device.
People
Ava – Pascal Koenig (co-founder).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater